# NuSirt Sciences Inc.: Form D filings

NuSirt Sciences Inc., a pharmaceuticals company in Nashville, TN, filed 3 Form D notices with the SEC between 2015 and 2016. The latest, on December 1, 2016, reports $2 million sold of a $2 million offering to 29 investors.

Find out what NuSirt Sciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20NuSirt%20Sciences%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=NuSirt%20Sciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnusirt-sciences-inc-1642239)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20NuSirt%20Sciences%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=NuSirt%20Sciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnusirt-sciences-inc-1642239)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Tennessee](https://specstream.ai/data/form-d/state/tennessee): 543 rows, by operating companies, filed since November 1, 2024, $27.15, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/tennessee
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3835 CLEGHORN AVENUE SUITE 200, Nashville, TN, 37215
- Phone: (615) 656-7898
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1642239

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 1, 2016 | New notice | $1,999,997 | $1,999,997 | $0 | 29 | Nov 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1642239/000164223916000003/0001642239-16-000003-index.htm) |
| Oct 13, 2015 | New notice | $8,000,142 | $4,000,071 | $4,000,071 | 28 | Sep 30, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1642239/000164223915000002/0001642239-15-000002-index.htm) |
| May 14, 2015 | New notice | $6,000,000 | $2,070,000 | $3,930,000 | 26 | May 7, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1642239/000164223915000001/0001642239-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Brian C. Laden | Director |  |
| Vaughn C. Bryson | Director |  |
| Joseph C. Cook, Jr. | Executive Officer, Director |  |
| Eric C. Satz | Director |  |
| Michael C. Zemel | Executive Officer, Director |  |
| Barbara Cannon | Executive Officer |  |

[Every Form D from the week of Nov 28, 2016](https://specstream.ai/data/form-d/week/2016-11-28) · [All recent filings in Tennessee](https://specstream.ai/data/form-d/state/tennessee) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what NuSirt Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).